ObsEva to Present at the H.C. Wainwright Global Investment 2022 Conference

Rhea-AI Summary

ObsEva SA (NASDAQ: OBSV) announced a corporate update to be presented at the H.C. Wainwright Global Investment Conference, scheduled virtually and in Miami from May 23 – 26, 2022. The presentation will be available on-demand starting at 10:30 a.m. EST on May 24, 2022. ObsEva focuses on developing and commercializing therapies for women’s reproductive health, addressing conditions like uterine fibroids and endometriosis. Interested parties can access the webcast through the conference portal or via the company's website under the “Events Calendar” section.

News Market Reaction – OBSV

+5.41%

+5.41% Session move

In the trading session that priced this news, OBSV gained 5.41%, reflecting a notable positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

GENEVA, Switzerland May 16, 2022 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies for women’s health, today announced that Company Management will provide a corporate update at the upcoming H.C. Wainwright Global Investment Conference, taking place virtually and in Miami, Florida from May 23 – 26, 2022.

The presentation will be available on-demand through the H.C. Wainwright conference portal, starting at 10:30 a.m. EST on Tuesday, May 24, 2022.

A webcast can be accessed here and will also be accessible under “Events Calendar” in the investors section of ObsEva’s website.

About ObsEva

ObsEva is a biopharmaceutical company developing and commercializing novel therapies to improve women’s reproductive health and pregnancy. Through strategic in-licensing and disciplined drug development, ObsEva has established a late-stage clinical pipeline with development programs focused on new therapies for the treatment of uterine fibroids, endometriosis, and preterm labor. ObsEva is listed on the Nasdaq Global Select Market and is traded under the ticker symbol “OBSV” and on the SIX Swiss Exchange where it is traded under the ticker symbol “OBSN”. For more information, please visit www.ObsEva.com

 

For further information, please contact:
CEO Office contact
Shauna Dillon
shauna.dillon@obseva.ch
+41 22 552 1550

Investor Contact
Katja Bührer
Katja.buhrer@obseva.com

+1 (917) 969-3438

 

Attachment

• Press Release in Pdf

FAQ

What is the date of ObsEva's corporate update at the H.C. Wainwright Global Investment Conference?

ObsEva's corporate update will take place from May 23 – 26, 2022.

What time will ObsEva's presentation be available on-demand during the conference?

The presentation will be available on-demand starting at 10:30 a.m. EST on May 24, 2022.

How can I access ObsEva's presentation at the conference?

The presentation can be accessed through the H.C. Wainwright conference portal or on ObsEva's website under the 'Events Calendar' section.

What is the focus of ObsEva's development programs?

ObsEva develops therapies for women’s reproductive health, including treatments for uterine fibroids, endometriosis, and preterm labor.

What stock exchanges is ObsEva listed on?

ObsEva is listed on the NASDAQ under the ticker symbol OBSV and on the SIX Swiss Exchange as OBSN.